A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
Clinical trial NCT03942211 · TERMINATED
Trial details
- NCT number
- NCT03942211
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2023-04-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.